Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Early tumorigenesis is associated with the engagement of the DNA-damage checkpoint response (DDR). Cell proliferation and transformation induced by oncogene activation are restrained by cellular senescence. It is unclear whether DDR activation and oncogene-induced senescence (OIS) are causally linked. Here we show that senescence, triggered by the expression of an activated oncogene (H-RasV12) in normal human cells, is a consequence of the activation of a robust DDR. Experimental inactivation of DDR abrogates OIS and promotes cell transformation. DDR and OIS are established after a hyper-replicative phase occurring immediately after oncogene expression. Senescent cells arrest with partly replicated DNA and with DNA replication origins having fired multiple times. In vivo DNA labelling and molecular DNA combing reveal that oncogene activation leads to augmented numbers of active replicons and to alterations in DNA replication fork progression. We also show that oncogene expression does not trigger a DDR in the absence of DNA replication. Last, we show that oncogene activation is associated with DDR activation in a mouse model in vivo. We propose that OIS results from the enforcement of a DDR triggered by oncogene-induced DNA hyper-replication.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inhibition of DDR signalling kinases (ATM, ATR, CHK1 and CHK2) allows senescent cells to re-enter the cell cycle7,24,25”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [7]
In the citing paper
“Oncogene activation is a powerful inducer of cellular senescence. Oncogene expression triggers an initial hyperproliferative phase that is intrinsically associated with altered DNA replication, which eventually engages DDR pathways and causes senescence7,8,39”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [7]
In the citing paper
“In normal cells, however, oncogenic RAS causes genotoxic stress and senescence [ 57 , 58 ], inducing a SASP and thereby conferring complex cell-nonautonomous oncogenic activities.”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [57]
In the citing paper
“Indeed, most oncogenes that have been studied in the literature cause replication stress by increasing origin firing and triggering DNA damage [12, 29]”
From The Spi1/PU.1 transcription factor accelerates replication fork progression by increasing PP1 phosphatase in leukemia (2017) · cites this paper as [12]
In the citing paper
“It has been shown that one mechanism for the link between the initial mitotic reaction and senescence induction is the S-phase-associated DDR: The oncogenic stress drives increased DNA replication origins, leading to accumulation of incomplete replication intermediates, resulting in DNA damage and activation of the DDR kinases (ATM, ATR, CHK2, and CHK1) (Bartkova et al. 2006; Di Micco et al. 2006;”
From Cellular senescence and its effector programs (2014) · cites this paper as Di Micco et al. 2006
14 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Oncogenic activity of Cdc6 through repression of the INK4/ARF locus
Gonzalez, S., Klatt, P., Delgado, S., Conde, E., Lopez-Rios, F., Sanchez-Cespedes, M., Mendez, J., Antequera, F., & Serrano, M. (2006) · Nature · doi:10.1038/nature04585 · Cited by 186
RetractedA biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Cited by
Items 701–800 of 1,011
Spaapen, F., van den Akker, G., Caron, M. M. J., Prickaerts, P., Rofel, C., Dahlmans, V. E. H., Surtel, D. A., Paulis, Y. W. J., Schweizer, F., Welting, T. J. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058083 · Cited by 54
“Activation of DDR was confirmed by detection of phosphorylated histone variant H2A.”
BackgroundInfluentialShen, J., Curtis, C. N., Tavaré, S., & Tower, J. (2009) · Aging · doi:10.18632/aging.100018 · Cited by 56
Acin, S., Li, Z., Mejia, O., Roop, D. R., El‐Naggar, A. K., & Caulin, C. (2011) · The Journal of Pathology · doi:10.1002/path.2971 · Cited by 49
Rieck, S., Zhang, J., Li, Z., Liu, C., Naji, A., Takane, K. K., Fiaschi‐Taesch, N., Stewart, A. F., Kushner, J. A., & Kaestner, K. H. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1019 · Cited by 55
Jailbreak: Oncogene-induced senescence and its evasion
MDuff, F. K. E., & Turner, S. D. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.07.004 · Cited by 56
Drosos, Y., Escobar, D., Chiang, M.-Y., Roys, K., Valentine, V. A., Valentine, M. B., Rehg, J. E., Sahai, V., Begley, L., Ye, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11661-8 · Cited by 54
Dormant origins and fork protection mechanisms rescue sister forks arrested by transcription
Brambati, A., Zardoni, L., Achar, Y. J., Piccini, D., Galanti, L., Colosio, A., Foiani, M., & Liberi, G. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx945 · Cited by 48
“The activation of oncogenes promotes replication stress (2,3) that has been proposed to account for the formation of precancerous DNA lesions in early tumorigenesis (1).”
BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites
Hu, Z., Mi, S., Zhao, T. S., Peng, C., Peng, Y., Chen, L., Zhu, W., Yao, Y., Song, Q., Li, X., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019104133 · Cited by 55
“Recent studies show that following formation of DSBs, bidirectional transcription events adjacent to the breaks generate small RNAs that trigger the DNA damage response by local RNA: RNA interactions (Di Micco et al , 2006; Francia et al , 2012).”
InfluentialCancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing
Mongiardi, M. P., Pellegrini, M., Pallini, R., Levi, A., & Falchetti, M. L. (2021) · Cancers · doi:10.3390/cancers13030484 · Cited by 53
Clothing up DNA for all seasons: Histone chaperones and nucleosome assembly pathways
Rocha, W., & Verreault, A. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.03.006 · Cited by 53
Targeting the DNA damage response and repair in cancer through nucleotide metabolism
Helleday, T., & Rudd, S. G. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13227 · Cited by 52
Lee, J. (2024) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2024.102808 · Cited by 57
Miyasaka, Y., Nagai, E., Yamaguchi, H., Fujii, K., Inoue, T., Ohuchida, K., Yamada, T., Mizumoto, K., Tanaka, M., & Tsuneyoshi, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0032 · Cited by 51
Liontos, M., Niforou, K., Velimezi, G., Vougas, K. N., Evangelou, K., Apostolopoulou, K., Vrtěl, R., Damalas, A. F., Kontovazenitis, P., Kotsinas, A., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081160 · Cited by 53
Chk1 is essential for chemical carcinogen-induced mouse skin tumorigenesis
Tho, L. M., Libertini, S., Rampling, R., Sansom, O. J., & Gillespie, D. A. (2011) · Oncogene · doi:10.1038/onc.2011.326 · Cited by 49
“Importantly, evidence suggests that checkpoint activation may present a barrier to tumorigenesis by directing incipient cancer cells to terminal fates such as senescence or apoptosis (”
BackgroundThe WRN and MUS81 proteins limit cell death and genome instability following oncogene activation
Murfuni, I., Nicolai, S., Baldari, S., Crescenzi, M., Bignami, M., Franchitto, A., & Pichierri, P. (2012) · Oncogene · doi:10.1038/onc.2012.80 · Cited by 49
DNA double strand break responses and chromatin alterations within the aging cell
Klement, K., & Goodarzi, A. A. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.003 · Cited by 53
Autoimmunity checkpoints as therapeutic targets in B cell malignancies
Müschen, M. (2018) · Nature reviews. Cancer · doi:10.1038/nrc.2017.111 · Cited by 51
Mouse Models of Accelerated Cellular Senescence
Yousefzadeh, M. J., Melos, K. I., Angelini, L., Burd, C. E., Robbins, P. D., & Niedernhofer, L. J. (2019) · Methods in Molecular Biology · doi:10.1007/978-1-4939-8931-7_17 · Cited by 47
Role of genomic instability in human carcinogenesis
Moon, J. J., Lu, A., & Moon, C. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219826031 · Cited by 55
Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells
Rysanek, D., Vašicová, P., Kolla, J. N., Sedlák, D., Anděra, L., Bártek, J., & Hodný, Z. (2022) · Aging · doi:10.18632/aging.204207 · Cited by 50
“com 11 AGING Cellular senescence induced by activated oncogenes [58, 59] resulting in development of benign preneoplastic lesions (see, e.”
Anderson, C. W., & Appella, E. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00264-3 · Cited by 54
Biavasco, R., Lettera, E., Giannetti, K., Gilioli, D., Beretta, S., Conti, A., Scala, S., Cesana, D., Gallina, P., Norelli, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24876-1 · Cited by 47
Senescence and the Pro-tumorigenic Stroma
Alspach, E., Fu, Y., & Stewart, S. A. (2013) · Critical Reviews in Oncogenesis · doi:10.1615/critrevoncog.2014010630 · Cited by 47
Shaikh, N., Mazzagatti, A., Angelis, S. D., Johnson, S. C., Bakker, B., Spierings, D. C. J., Wardenaar, R., Maniati, E., Wang, J., Boemo, M. A., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02781-0 · Cited by 51
Bártek, J. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.07.006 · Cited by 50
“Probably the best example of a therapeutic potential among the emerging DDR-targeted drugs are the PARP inhibitors (Bryant et al., 2005; Farmer et al., 2005), now under scrutiny in numerous clinical trials, at various phases and for diverse types of malignancies.”
BackgroundThe DNA damage response in viral-induced cellular transformation
Nikitin, P. A., & Luftig, M. A. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.612 · Cited by 49
“…characterisation of these pathways, the functional significance of the DDR activation was revealed by genetic studies indicating that ATM and Chk2 were critical tumour suppressors downstream of oncogenes including H-RasV12, Mos, Cdc6, and cyclin E (Bartkova et al, 2006; Di Micco et al, 2006).”
BackgroundCellular Senescence, Neurological Function, and Redox State
Maciel-Barón, L. Á., Moreno-Blas, D., Morales-Rosales, S. L., González-Puertos, V. Y., López-Díazguerrero, N. E., Torres, C., Castro-Obregón, S., & Königsberg, M. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7112 · Cited by 45
Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors
Tuna, M., Amos, C. I., & Mills, G. B. (2019) · Oncotarget · doi:10.18632/oncotarget.26777 · Cited by 59
Cellular senescence and hematological malignancies: From pathogenesis to therapeutics
Hu, D., Yuan, S., Zhong, J., Liu, Z., Wang, Y., Liu, L., Li, J., Wen, F., Liu, J., & Zhang, J. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107817 · Cited by 49
Wu, W., Barwacz, S. A., Bhowmick, R., Lundgaard, K., Dinis, M. M. G., Clausen, M., Kanemaki, M. T., & Liu, Y. (2023) · Nature Communications · doi:10.1038/s41467-023-35992-5 · Cited by 51
Okudela, K., Woo, T., & Kitamura, H. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02580.x · Cited by 45
Pseudolaric acid B induces apoptosis, senescence, and mitotic arrest in human breast cancer MCF-7
Yu, J., Qiao, C. U. I., Jiang, Y., Yang, W., Tashiro, S., Onodera, S., & Ikejima, T. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00706.x · Cited by 47
Gruhne, B., Kamranvar, S. A., Masucci, M. G., & Sompallae, R. R. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.07.005 · Cited by 49
Exploring and exploiting the systemic effects of deregulated replication licensing
Petrakis, T. G., Komseli, E.-S., Papaioannou, M. D., Vougas, K., Polyzos, A., Myrianthopoulos, V., Mikros, E., Trougakos, I. P., Thanos, D., Branzei, D., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.12.002 · Cited by 52
“[50] Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, et al.”
BackgroundThe Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer
Arai, H., Elliott, A., Xiu, J., Wang, J., Battaglin, F., Kawanishi, N. K., Soni, S., Zhang, W., Millstein, J., Sohal, D. P. S., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3635 · Cited by 49
Skp2 Regulates G2/M Progression in a p53-dependent Manner
Hu, R., & Aplin, A. E. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-11-1137 · Cited by 47
Cheng, K., Grisendi, S., Clohessy, J. G., Majid, S. M., Bernardi, R., Sportoletti, P., & Pandolfi, P. P. (2007) · Oncogene · doi:10.1038/sj.onc.1210549 · Cited by 46
TGF-β/NF1/Smad4-mediated suppression of ANT2 contributes to oxidative stress in cellular senescence
Kretová, M., Sabová, L., Hodný, Z., Bártek, J., Kollárovič, G., Nelson, B. D., Hubáčková, S., & Luciaková, K. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.08.029 · Cited by 46
The many facets of the Tim-Tipin protein families’ roles in chromosome biology
McFarlane, R. J., Mian, S., & Dalgaard, J. Z. (2010) · Cell Cycle · doi:10.4161/cc.9.4.10676 · Cited by 47
Cellular Senescence as a Target in Cancer Control
Vergel, M., Marin, J. J., Estevez, P., & Carnero, A. (2011) · Journal of Aging Research · doi:10.4061/2011/725365 · Cited by 44
Alberghina, L., Gaglio, D., Gelfi, C., Moresco, R. M., Mauri, G., Bertolazzi, P., Messa, C., Gilardi, M. C., Chiaradonna, F., & Vanoni, M. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00362 · Cited by 53
“In normal cells, that possess a functional DNA damage checkpoint machinery, DDR stimulation by oncogenic ras brings to cell cycle arrest in a process called oncogene-induced-senescence (OIS) (Serrano et al., 1997; Ferbeyre et al., 2002; Di Micco et al., 2006).”
BackgroundSoza, S., Leva, V., Vago, R., Ferrari, G. M., Mazzini, G., Biamonti, G., & Montecucco, A. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01730-08 · Cited by 47
“Recently, DNA damage has been shown to induce cell senescence (6).”
BackgroundConserved RB functions in development and tumor suppression
Gordon, G. M., & Du, W. (2011) · Protein & Cell · doi:10.1007/s13238-011-1117-z · Cited by 53
“Indeed, the DNA damage response to aberrant replication is known to be critical for inducing senescence upon oncogene activation (Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundNoda, A., Hirai, Y., Hamasaki, K., Mitani, H., Nakamura, N., & Kodama, Y. (2012) · Journal of Cell Science · doi:10.1242/jcs.101006 · Cited by 55
Mutant p53 establishes targetable tumor dependency by promoting unscheduled replication
Singh, S., Vaughan, C. A., Frum, R. A., Grossman, S. R., Deb, S., & Deb, S. P. (2017) · Journal of Clinical Investigation · doi:10.1172/jci87724 · Cited by 49
Ataxia-Telangiectasia Mutated Modulation of Carbon Metabolism in Cancer
Dahl, E. S., & Aird, K. M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00291 · Cited by 47
“One of the underlying mechanisms of OIS is increased replication stress, leading to DNA damage accumulation and cell cycle arrest (63, 64).”
BackgroundA tale of the good and bad: Cell senescence in bone homeostasis and disease
(2019) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.03.005 · Cited by 45
Senescence and Immunoregulation in the Tumor Microenvironment
Ruhland, M. K., & Alspach, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.754069 · Cited by 52
ATM Mediates pRB Function To Control DNMT1 Protein Stability and DNA Methylation
Shamma, A., Suzuki, M., Hayashi, N., Kobayashi, M., Sasaki, N., Nishiuchi, T., Doki, Y., Okamoto, T., Kohno, S., Muranaka, H., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01597-12 · Cited by 45
“DDR activation has been demonstrated to contribute to oncogene-induced senescence (OIS) (41); however, the mechanism linking the DDR to cellular senescence was not known.”
BackgroundWolyniec, K., Wotton, S., Kilbey, A., Jenkins, A., Terry, A., Peters, G., Stocking, C., Cameron, E., & Neil, J. C. (2009) · Oncogene · doi:10.1038/onc.2009.101 · Cited by 44
The Mre11 Complex Suppresses Oncogene-Driven Breast Tumorigenesis and Metastasis
Gupta, G. P., Vanness, K., Barlas, A., Manova-Todorova, K. O., Wen, Y. H., & Petrini, J. H. J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.001 · Cited by 48
“Despite supportive genetic data from in vitro and tumor inoculation studies (Bartkova et al., 2006; Di Micco et al., 2006), causal demonstration that the oncogene-induced DDR suppresses tumorigenesis within a tissue context remains limited (Gorrini et al., 2007; Squatrito et al., 2010; Takacova et…”
Backgroundp53-Dependent Induction of Prostate Cancer Cell Senescence by the PIM1 Protein Kinase
Zemskova, M., Lilly, M. B., Lin, Y.-W., Song, J. H., & Kraft, A. S. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0174 · Cited by 48
“OIS has been linked to DNA replicative stress, possibly through the induction of reactive oxygen species (81, 82) marked by aberrant premature termination of replication fork progression leading DNA breakage, the DDR response, and the induction of senescence (34, 83).”
Preserving the genome by regulating chromatin association with the nuclear envelope
Bermejo, R., Kumar, A., & Foiani, M. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.05.007 · Cited by 44
Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice
Xue, L., Nolla, H., Suzuki, A., Mak, T. W., & Winoto, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712059105 · Cited by 44
“Oncogene-induced senescence is thought to be part of the ATM DNA damage pathway that involves many proteins, including phosphorylation/activation of p53, chk1, chk2, -H2AX, and ATM (19, 24).”
BackgroundDNA Replication Stress and Cancer: Cause or Cure?
Taylor, E. M., & Lindsay, H. D. (2015) · Future Oncology · doi:10.2217/fon.15.292 · Cited by 49
Histone deficiency and accelerated replication stress in T cell aging
Kim, C., Jin, J., Ye, Z., Jadhav, R. R., Gustafson, C. E., Hu, B., Cao, W., Tian, L., Weyand, C. M., & Goronzy, J. J. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143632 · Cited by 47
“Importantly, activation of p53 by DNA damage kinases is involved in this process (43, 44), in part by inducing downstream targets including p21 and thereby inhibiting the cell cycle (45).”
BackgroundMYC-Induced Replicative Stress: A Double-Edged Sword for Cancer Development and Treatment
Curti, L., & Campaner, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126168 · Cited by 47
“On the other hand, it can also act as an anticancer barrier due to its tumor-suppressive activity at the early stages of cancer development [47,58,87].”
BackgroundSuppression of Apoptosis by PIF1 Helicase in Human Tumor Cells
Gagou, M. E., Ganesh, A. N., Thompson, R. H., Phear, G. A., Sanders, C. M., & Meuth, M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4404 · Cited by 49
“It has been reported that oncogene activation and the loss of control of entry into Sphase may lead to chronic DNA replication stress in many types of tumor cells (29, 30).”
BackgroundHowXenopus laevisembryos replicate reliably: Investigating the random-completion problem
Yang, S. C., & Bechhoefer, J. (2008) · Physical Review E · doi:10.1103/physreve.78.041917 · Cited by 44
Bub1: Escapades in a Cellular World
Williams, G. L., Roberts, T. M., & Gjoerup, O. V. (2007) · Cell Cycle · doi:10.4161/cc.6.14.4493 · Cited by 53
PTEN deletion in luminal cells of mature prostate induces replication stress and senescence in vivo
Parisotto, M., Grelet, E., El Bizri, R., Dai, Y., Terzic, J., Eckert, D., Gargowitsch, L., Bornert, J.-M., & Metzger, D. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171207 · Cited by 43
“PTEN deficiency in PECs induces replication stress Because DDR is an inducer of OIS (Bartkova et al., 2006; Di Micco et al., 2006; Mallette et al., 2007), we investigated the levels of phosphohistone H2AX S139 (γH2AX), a faithful marker of DDR activation (Rogakou et al., 1998; Mah et al., 2010).”
BackgroundOncogene‐induced cellular senescence elicits an anti‐ Warburg effect
Li, M., Durbin, K. R., Sweet, S. M. M., Tipton, J. D., Zheng, Y., & Kelleher, N. L. (2013) · PROTEOMICS · doi:10.1002/pmic.201200298 · Cited by 43
“Expression of a variety of oncogenes, including HRAS [6], BRAF [7], E2F1 [8], and MYC [9], drives a burst of cell hyperproliferation followed by a proliferation slow down and eventually cell growth arrest.”
BackgroundDeregulated transcription factors in the emerging cancer hallmarks
Hasan, A., Khan, N. A., Shahab Uddin, M. S., Khan, A. Q., & Steinhoff, M. S. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.12.001 · Cited by 48
Fan, S., Wang, W., Che, W., Xu, Y., Jin, C., Dong, L., & Xia, Q. (2025) · Metabolites · doi:10.3390/metabo15030201 · Cited by 50
Finn, K. J., & Li, J. J. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003192 · Cited by 40
Lee, T., Paola, D. D., Malina, A., Mills, J. R., Kreps, A., Große, F., Tang, H., Zannis‐Hadjopoulos, M., Larsson, O. S., & Pelletier, J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.568535 · Cited by 50
“(74) demonstrated that Ras-induced senescence resulted in accumulation of DNA breaks and activation of an ATR-dependent DNA damage response.”
BackgroundARF induction in response to DNA strand breaks is regulated by PARP1
Orlando, G., Khoronenkova, S. V., Dianova, I. I., Parsons, J. L., & Dianov, G. L. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1185 · Cited by 46
“Since published data on ARF protein induction by DNA damaging agents were inconsistent, oncogenes, such as c-Myc, were the only recognized ARF inducers (11), although the observation that c-Myc may induce DNA damage (41,42) was not widely accepted.”
BackgroundUnderstanding specific functions of PARP-2: new lessons for cancer therapy.
Ali, S. O., Khan, F. A., Galindo-Campos, M. A., & Yélamos, J. (2016) · RECERCAT (Consorci de Serveis Universitaris de Catalunya) · Cited by 61
Pathways from senescence to melanoma: focus on MITF sumoylation
Leclerc, J., Ballotti, R., & Bertolotto, C. (2017) · Oncogene · doi:10.1038/onc.2017.292 · Cited by 46
The role of vitamin D on redox regulation and cellular senescence
Sosa-Díaz, E., Cruz, E. Y. H., & Pedraza‐Chaverrí, J. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.10.003 · Cited by 44
Loss of hepatocyte cell division leads to liver inflammation and fibrosis
Dewhurst, M. R., Ow, J. R., Zafer, G., van Hul, N. K. M., Wollmann, H., Bisteau, X., Brough, D., Choi, H., & Kaldis, P. (2020) · PLOS Genetics · doi:10.1371/journal.pgen.1009084 · Cited by 42
“Additionally, excessive CDK2 activity in the absence of CDK1 leading to persistent DNA rereplication [15] can also trigger the DNA damage response due to increased stalled replication forks and exposure of single-stranded DNA at fragile sites in the genome [35, 60].”
BackgroundHuo, D., Chen, H., Cheng, Y., Song, X., Zhang, K., Li, M. J., & Xuan, C. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0397-3 · Cited by 42
Up‐regulation of PSF1 promotes the growth of breast cancer cells
Nakahara, I., Miyamoto, M., Shibata, T., Akashi‐Tanaka, S., Kinoshita, T., Mogushi, K., Oda, K., Ueno, M., Takakura, N., Mizushima, H., et al. (2010) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01442.x · Cited by 42
“The number of active replicons could be increased by c-Myc over-expression or oncogenic Ras expression in cancer cells (Di Micco et al. 2006; Dominguez-Sola et al. 2007).”
BackgroundChiantore, M. V., Vannucchi, S., Accardi, R., Tommasino, M., Percario, Z. A., Vaccari, G., Affabris, E., Fiorucci, G., & Romeo, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036909 · Cited by 64
RetractedRegulation and roles of Cdc7 kinase under replication stress
Yamada, M., Masai, H., & Bártek, J. (2014) · Cell Cycle · doi:10.4161/cc.29251 · Cited by 49
“This anti-cancer barrier provided by the DNA damage checkpoints precedes the activation of the ARF tumor suppressor, the second anti-cancer barrier,(76-80) and helps delay or prevent tumor progression by triggering senescence or cell death among the nascent cancer cells.(67,68,70,71) However, in those tumors that even…”
BackgroundAmemiya, Y., Yang, W., Benatar, T., Nofech‐Mozes, S., Yee, A., Kahn, H. K., Holloway, C. M. B., & Seth, A. K. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0921-0 · Cited by 45
“Recent evidence obtained in various scenarios of tumorigenesis has clarified that acutely available senescence may be recruited as an ultimate failsafe mechanism to blunt oncogenic activity in vivo, leading to growth-arrested premalignant lesions or interrupting the transformation process at a very early stage [ 22 ,…”
BackgroundNussinov, R., Tsai, C.-J., Muratcioglu, S., Jang, H., Gursoy, A., & Keskin, O. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2015.1100079 · Cited by 42
PRPF19 regulates p53-dependent cellular senescence by modulating alternative splicing of MDM4 mRNA
Yano, K., Takahashi, R., Shiotani, B., Abe, J., Shidooka, T., Sudo, Y., Yamamoto, Y., Kan, S., Sakagami, H., & Tahara, H. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100882 · Cited by 47
Human PIF1 helicase supports DNA replication and cell growth under oncogenic-stress
Gagou, M. E., Ganesh, A. N., Phear, G. A., Robinson, D. A., Petermann, E., Cox, A., & Meuth, M. (2014) · Oncotarget · doi:10.18632/oncotarget.2501 · Cited by 44
“Given that oncogene expression induces replication stress during early stages of tumorigenesis [27, 28] we aimed to investigate whether specific oncogene transformations of noncancerous cells could trigger PIF1-dependent mechanism(s) of DNA replication progression and recovery, ensuring cell growth and proliferation.”
BackgroundResultInfluentialAl‐Khalaf, H. H., Mohideen, P., Nallar, S. C., Kalvakolanu, D. V., & Aboussekhra, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.512640 · Cited by 45
“p16 is also involved in the cellular response toDNA damage, which leads to cell cycle arrest (6), senescence (7, 8), and/or apoptosis (9, 10).”
BackgroundMolecular chaperones regulate p53 and suppress senescence programs
Sherman, M. Y., Gabai, V. L., O’Callaghan-Sunol, C., & Yaglom, J. A. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.05.036 · Cited by 46
The Viral Oncoprotein Tax Sequesters DNA Damage Response Factors by Tethering MDC1 to Chromatin
Belgnaoui, S. M., Fryrear, K. A., Nyalwidhe, J. O., Guo, X., & Semmes, O. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.146373 · Cited by 44
Telomere dysfunction and stem cell ageing
Ju, Z., & Rudolph, K. L. (2007) · Biochimie · doi:10.1016/j.biochi.2007.09.006 · Cited by 48
Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence
Shin, J., Yang, J., Lee, J. C., & Baek, K. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.08.014 · Cited by 44
Tripathi, K. K., Mani, C., Barnett, R. M., Nalluri, S., Bachaboina, L., Rocconi, R. P., Athar, M., Owen, L. B., & Palle, K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.606483 · Cited by 41
Mitogen-Induced B-Cell Proliferation Activates Chk2-Dependent G1/S Cell Cycle Arrest
Nikitin, P. A., Price, A. M., McFadden, K., Yan, C. M., & Luftig, M. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087299 · Cited by 43
Perturbations in the Replication Program Contribute to Genomic Instability in Cancer
Blumenfeld, B., Ben‐Zimra, M., & Simon, I. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061138 · Cited by 42
“H-RasV12 Oxidative stress, hyperreplication [55,58,60,61]”
BackgroundBLM prevents instability of structure-forming DNA sequences at common fragile sites
Wang, H., Li, S., Zhang, H., Wang, Y., Hao, S., & Wu, X. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007816 · Cited by 43
Telomere Maintenance and DNA Damage Responses during Lung Carcinogenesis
Lantuéjoul, S., Raynaud, C. M., Salameire, D., Gazzéri, S., Moro‐Sibilot, D., Soria, J., Brambilla, C., & Brambilla, E. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0142 · Cited by 46
Iotti, G., Longobardi, E., Masella, S., Dardaei, L., Santis, F. D., Micali, N., & Blasi, F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105216108 · Cited by 45
“The question, therefore, becomes whether Prep1 deficiency directly increases DNA damage or causes replication stress (41, 42).”
BackgroundEwing, S. J., Zhu, S., Zhu, F., House, J. S., & Smart, R. C. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.105 · Cited by 49
“genes including Myc, Ras, Raf, cyclin E, Cdc25A, and E2F1 can engage DNA-damage response pathways, resulting in activation of p53 and the induction of apoptosis or senescence.(18,20,38) The important decision of cell survival or cell death in response to different stimuli is likely controlled by more than one signal.”
Masterson, J. C., & O’Dea, S. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e32825209f6 · Cited by 46
Recent Advancements in DNA Damage–Transcription Crosstalk and High-Resolution Mapping of DNA Breaks
Vitelli, V., Galbiati, A., Iannelli, F., Pessina, F., Sharma, S., & di Fagagna, F. D. (2017) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091416-035314 · Cited by 43
Cellular senescence and neurodegeneration
Holloway, K., Neherin, K., Dam, K. U., & Zhang, H. (2023) · Human Genetics · doi:10.1007/s00439-023-02565-x · Cited by 43
DNA damage response(DDR): a link between cellular senescence and human cytomegalovirus
Wu, X., Zhou, X., Wang, S., & Mao, G. (2023) · Virology Journal · doi:10.1186/s12985-023-02203-y · Cited by 49
“Oncogene-induced senescence (OIS) is characterized by substantial activation of the DDR pathway and the formation of DDR foci in senescent cells (also known as senescence-associated DNA-damage foci; SDFs) [7, 67, 72, 73].”
BackgroundModulation of gut microbiome in the treatment of neurodegenerative diseases: A systematic review
Mincic, A. M., Antal, M., Filip, L. A., & Miere, D. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.05.036 · Cited by 46
Engström, W., Darbre, P. D., Eriksson, S., Gulliver, L., Hultman, T., Karamouzis, M. V., Klaunig, J. E., Mehta, R., Moorwood, K., Sanderson, J. T., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv030 · Cited by 43
“Interestingly, oncogene H-RasV12-induced senescence is associated with DNA damage response in normal cells, suggesting an inhibitory role in tumourigenesis through replicative immortality pathways (147).”
BackgroundHerrick, J., & Bensimon, A. (2008) · Chromosoma · doi:10.1007/s00412-007-0145-1 · Cited by 40
Self-citationSnoN functions as a tumour suppressor by inducing premature senescence
Pan, D., Zhu, Q., & Luo, K. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.250 · Cited by 45
“Second, the DNA damage pathway is a critical mediator of The EMBO Journal VOL 28 | NO 22 | 2009 &2009 European Molecular Biology Organization3510 oncogene-induced senescence (Bartkova et al, 2006; Di Micco et al, 2006; Mallette and Ferbeyre, 2007).”
Background
Metadata
- Authors
- Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., Maestro, R., Giuseppe Pelicci, P., & d’Adda di Fagagna, F.
- Affiliations
- IFOM (IT)
- European Institute of Oncology (IT)
- Centro di Riferimento Oncologico (IT)
- Institut Pasteur (FR)
- Genomic Vision (France) (FR)
- Venue
- Nature
- Published
- 2006-11
- Volume
- 444
- Issue
- 7119
- Pages
- 638-642
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2121371748
- Cited by
- 1,821
- References
- 30
- Citations by year
- 2026: 50 · 2025: 58 · 2024: 62 · 2023: 76 · 2022: 80 · 2021: 118 · 2020: 84 · 2019: 81 · 2018: 104 · 2017: 84 · 2016: 110 · 2015: 89 · 2014: 118 · 2013: 107 · 2012: 115
- FWCI
- 58.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- oncogene-induced senescence, DNA damage response, H-Ras V12, origin of replication, DNA replication fork progression, cell transformation, carcinogenesis, senescence markers, DNA combing
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Cells, Cultured, DNA Replication, Genetic Markers, Humans, Genes, ras, Cellular Senescence, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.